FindTrial
Sign In

Multi-center study on intelligent accurate diagnosis and critical illness prediction of novel coronavirus pneumonia (COVID-19) with multimodal imaging

Multi-center study on intelligent accurate diagnosis and critical illness prediction of novel coronavirus pneumonia (COVID-19) with multimodal imaging

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036217
Enrollment
Unknown
Registered
2020-08-21
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Gold Standard:Etiological examination
Index test:Multimodal&#32
image&#32
assisted&#32
diagnosis&#32
system&#32
for&#32
COVID-19.

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with pulmonary infection with definite etiological examination; 2. Thin slice CT image data; 3. DR, Thin-slice CT and MR images were of good quality (Liszt score >=4 points) without obvious respiratory motion artifacts; 4. Patients who have undergone more than one thin-slice CT examination.

Exclusion criteria

Exclusion criteria: 1. Patients with unclear etiology or complicated with multiple different types of pneumonia; 2. DR, THIN slice CT or MRI image motion artifact or noise significant.

Design outcomes

Primary

MeasureTime frame
Accuracy;SEN, SPE, AUC of ROC;—

Countries

China

Contacts

Public ContactYuxin Shi

Shanghai Public Health Clinical Center

shiyx828288@163.com+86 18930810066

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026